KYMR Form 144 lists proposed Common Stock resales

The issuer listed Common Stock for sale under Form 144 with Nasdaq listed securities; the notice is dated 06/29/2026.

Rhea-AI Filing Summary

The issuer listed Common Stock for sale under Form 144 with Nasdaq listed securities; the notice is dated 06/29/2026. The excerpt lists multiple proposed sales by holders including Atlas Venture Funds and Bruce Booth with trade dates from 04/15/2026 through 06/26/2026.

Insights

Securities Compliance Counsel

Routine Form 144 resale notices by pre-existing holders.

The filing lists proposed sales of Common Stock by several holders, including named venture funds and an individual, across specific trade dates in April and June 2026. These entries record the intended transactions and associated dollar figures.

Execution, timing, and whether all listed amounts are sold depend on market actions and any transfer restrictions; subsequent SEC or broker filings will show completed transactions.

Key Figures

Form date: 06/29/2026 Atlas Venture Fund X sale example: 480,992 shares, $57,122,898.52 Atlas Venture Opportunity Fund I sale example: 67,329 shares, $7,996,032.44 +1 more

4 metrics

Form date 06/29/2026 Form 144 notice date

Atlas Venture Fund X sale example 480,992 shares, $57,122,898.52 trade date 06/25/2026

Atlas Venture Opportunity Fund I sale example 67,329 shares, $7,996,032.44 trade date 06/25/2026

Bruce Booth sale example 11,741 shares, $1,056,443.24 trade date 06/17/2026

Key Terms

Form 144, Private Placement, Issuer

3 terms

Form 144 regulatory

"144: Securities Sold During The Past 3 Months"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Private Placement market

"Common Stock | 03/11/2020 | Private Placement"

A private placement is a sale of securities directly to a selected group of investors, typically institutions or accredited investors, instead of through a public offering. It lets a company raise money faster and with fewer regulatory steps; for existing shareholders it matters because the newly issued shares, often sold at a discount, increase the share count and can dilute their ownership.

Issuer regulatory

"Common Stock | 03/11/2020 | Private Placement | Issuer"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does KYMR's Form 144 dated 06/29/2026 disclose?

The Form 144 discloses proposed resale notices for Common Stock dated 06/29/2026. It lists specific holders, trade dates from 04/15/2026 to 06/26/2026, and share counts with corresponding dollar amounts for each proposed sale.

Which holders are shown selling shares in KYMR's Form 144?

The excerpt shows sales by Atlas Venture Fund X, L.P., Atlas Venture Opportunity Fund I, L.P., and individual Bruce Booth. Each holder has multiple trade-date entries with specific share counts and dollar figures listed in the filing excerpt.

Do the listed dollar amounts in KYMR's Form 144 represent proceeds?

The filing shows dollar figures adjacent to each trade-date and share count, presented as amounts tied to those proposed sales. The document lists these numbers alongside each trade entry but does not state any allocation of proceeds or uses of funds.

Are the proposed sales in KYMR's Form 144 completed once filed?

Filing Form 144 notifies of proposed sales but does not confirm completion. The excerpt lists intended trade dates and quantities; execution and final sale reporting would appear in separate broker or SEC transaction records if and when trades settle.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/29/2026 - 05:51 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001628098
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	KYMERA THERAPEUTICS, INC.
SEC File Number	001-39460
Address of Issuer	500 North Beacon Street 4th Floor Watertown MASSACHUSETTS 02472
Phone	8572855300
Name of Person for Whose Account the Securities are To Be Sold	Atlas Venture Fund X, LP
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Shareholder

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Merrill Lynch 555 California Street 18th Floor San Francisco CA 94104	66177	7155057.24	82257588	06/29/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	03/11/2020	Private Placement	Issuer			66177	03/11/2020	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Atlas Venture Fund X, L.P. 300 Technology Sq Ste 8 Cambridge MA 02139	Common	04/15/2026	2750	247765.57
Atlas Venture Fund X, L.P. 300 Technology Sq Ste 8 Cambridge MA 02139	Common	04/22/2026	88	7926.6
Atlas Venture Fund X, L.P. 300 Technology Sq Ste 8 Cambridge MA 02139	Common	06/17/2026	92169	8330667.41
Atlas Venture Fund X, L.P. 300 Technology Sq Ste 8 Cambridge MA 02139	Common	06/18/2026	100928	9185730.49
Atlas Venture Fund X, L.P. 300 Technology Sq Ste 8 Cambridge MA 02139	Common	06/22/2026	243976	24182608.35
Atlas Venture Fund X, L.P. 300 Technology Sq Ste 8 Cambridge MA 02139	Common	06/23/2026	1235	123470.07
Atlas Venture Fund X, L.P. 300 Technology Sq Ste 8 Cambridge MA 02139	Common	06/24/2026	118178	11877944.68
Atlas Venture Fund X, L.P. 300 Technology Sq Ste 8 Cambridge MA 02139	Common	06/25/2026	480992	57122898.52
Atlas Venture Fund X, L.P. 300 Technology Sq Ste 8 Cambridge MA 02139	Common	06/26/2026	410427	45267758.67
Atlas Venture Opportunity Fund I, L.P. 300 Technology Sq Ste 8 Cambridge MA 02139	Common	04/15/2026	385	34687.18
Atlas Venture Opportunity Fund I, L.P. 300 Technology Sq Ste 8 Cambridge MA 02139	Common	04/22/2026	12	1080.9
Atlas Venture Opportunity Fund I, L.P. 300 Technology Sq Ste 8 Cambridge MA 02139	Common	06/17/2026	12902	1166143.4
Atlas Venture Opportunity Fund I, L.P. 300 Technology Sq Ste 8 Cambridge MA 02139	Common	06/18/2026	14128	1285827.52
Atlas Venture Opportunity Fund I, L.P. 300 Technology Sq Ste 8 Cambridge MA 02139	Common	06/22/2026	34152	3385105.26
Atlas Venture Opportunity Fund I, L.P. 300 Technology Sq Ste 8 Cambridge MA 02139	Common	06/23/2026	173	17295.81
Atlas Venture Opportunity Fund I, L.P. 300 Technology Sq Ste 8 Cambridge MA 02139	Common	06/24/2026	16542	1662618.77
Atlas Venture Opportunity Fund I, L.P. 300 Technology Sq Ste 8 Cambridge MA 02139	Common	06/25/2026	67329	7996032.44
Atlas Venture Opportunity Fund I, L.P. 300 Technology Sq Ste 8 Cambridge MA 02139	Common	06/26/2026	57451	6336517.83
Bruce Booth 300 Technology Sq Ste 8 Cambridge MA 02139	Common	04/14/2026	4159	374199.56
Bruce Booth 300 Technology Sq Ste 8 Cambridge MA 02139	Common	04/15/2026	2200	197895.00
Bruce Booth 300 Technology Sq Ste 8 Cambridge MA 02139	Common	04/22/2026	5900	530746.25
Bruce Booth 300 Technology Sq Ste 8 Cambridge MA 02139	Common	06/17/2026	11741	1056443.24

144: Remarks and Signature

Remarks
Date of Notice	06/29/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	12/11/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Ommer Chohan
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)